The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) as a single-agent ...
CMS is expanding coverage for remote patient monitoring in its 2026 Medicare Physician Fee Schedule, while a major payer is scaling back reimbursement to two specific use cases.
What is old is new again, and Modular Open Systems Approach (MOSA) is no different. MOSA is an acquisition and design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback